The TH HSV REC-003 trial was a phase 1/2 study that evaluated the reactogenicity, safety, immune response, and efficacy of GSK3943104, an HSV-targeted immunotherapy in individuals aged 18 to 60 years ...

Vaginal estrogen, vaginal DHEA, oral ospemifene, vaginal moisturizers may be beneficial for some genitourinary symptoms.

LIBERTY-BP ADEPT trial evaluated the safety and efficacy of dupilumab in 106 adults with moderate to severe bullous pemphigoid.

Study C of the phase 3 LIBERTY-CUPID trial evaluated dupilumab as add-on therapy to standard of care antihistamines in biologic-naïve patients with CSU who remained symptomatic despite antihistamine ...

HealthDay News — Taking blood pressure (BP) medications in the morning or at night does not impact outcomes, according to a study presented at the annual meeting of the European Society of Cardiology, ...

Ojji, PhD, from the University of Abuja in Nigeria, and colleagues compared the effectiveness and safety of a novel low-dose triple-pill protocol with a standard-care protocol for lowering blood ...

HealthDay News — Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at the annual meeting of The Menopause Society, held from ...

Users take hearing tests on iPhones or iPads running iOS 18, and then their AirPods make "personalized dynamic adjustments" to allow them to hear.

However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor ...

HealthDay News — Higher consumption of oats, gluten-containing cereals, and fruits by young children is associated with an increased risk for several type 1 diabetes measures, according to a study ...

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to plozasiran for use as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome ...